The fund overseen by Du Meng, Deputy General Manager and Chief Investment Officer of Morgan Funds, has unveiled its 2025 first-quarter report. Using the Morgan Emerging Power Hybrid Fund as a case study, the fund augmented its equity allocation during the initial quarter, intensifying investments in companies like Kelun Pharmaceutical, Huayou Cobalt, and Well Lead Electronics, while naming Sunway Co., Ltd. as its largest holding. In his report, Du Meng highlighted that 2025 is poised to mark a pivotal moment, with Chinese equities presenting a highly compelling prospect for long-term investment. He underscored that while he remains avidly attentive to the transformative prospects ushered in by AI, investment avenues extend far beyond this domain, encompassing a myriad of opportunities across various sectors such as construction machinery, chemicals, power batteries, innovative pharmaceuticals, and consumer goods. Du Meng holds the conviction that numerous enterprises with global competitive edge within the A-share market are currently severely undervalued.